Two eastern European countries struggling with low rates of vaccination against COVID-19 are seeing a sudden rush for jabs.
Coronavirus
Bloomberg: Eastern European vaccine skeptics embrace shots as cases soar
A patient registers receive a dose of the Oxford/AstraZeneca vaccine against the coronavirus disease, marketed under the name Covishield and produced in India, at an outpatient clinic in Kyiv on April 7, 2021.
